New oral medication may become tool against malaria
Sotrastaurin targets a specific enzyme to halt deadly spread of disease
Genetic research into how malaria enters and infects the human body has paved the way for a new oral medication that can now stop the deadly mosquito-borne disease in its tracks. Sotrastaurin, a drug that's already in clinical trials for use against another condition, may now become the frontline in battling a disease that has long plagued developing nations.
In tracking the progression of the disease, researchers learned that the malaria-infected female Anopheles mosquito injects about 1,000 parasites into the human bloodstream.
The microorganisms quickly reproduce after each one enters a red blood cell.
"Each parasite divides from one into say 24 to 32 parasites in 48 hours. So you can imagine that an initial thousand parasites can grow very fast," Doron Greenbaum, a professor of pharmacology at the University of Pennsylvania says.
Greenbaum and his colleagues discovered that inside the red blood cells, the parasites utilize a series of proteins to reproduce.
After robbing the cells of their nutrient machinery, the newborn parasites burst through the cell walls and back into the blood stream. It is here that they infect new blood cells, producing millions more offspring. After a one to two-week incubation period, the parasitic infection causes the often fatal symptoms associated with malaria. These commonly include high fevers, chills and sweats.
The malaria pathogen targets a particular enzyme called PKC, which weakens the protein chain, dismantling the cells and causing them to collapse. Sotrastaurin blocks P. falciparum's interaction with PKC.
Without that interactionthe parasites can't reproduce. "They are sort of trapped inside the host cell and if they can't get out, they can't continue their lifecycle and within a couple of hours, they start to die," Greenbaum said.
Greenbaum's team tested the experimental drug, now in clinical trials to prevent organ rejection in transplant patients. It was found that the compound dramatically reduced the number of P. falciparum malaria parasites in infected laboratory mice.
Because sotrastaurin targets human cellular proteins, Greenbaum says P. falciparum can't develop resistance to the drug which has made quinine and artemisinin drugs to treat malaria less effective in recent years.
© 2013, Distributed by NEWS CONSORTIUM.
- - -
Pope Benedict XVI's Prayer Intentions for January 2013
General Intention: The Faith of Christians. That in this Year of Faith Christians may deepen their knowledge of the mystery of Christ and witness joyfully to the gift of faith in him.
Missionary Intention: Middle Eastern Christians. That the Christian communities of the Middle East, often discriminated against, may receive from the Holy Spirit the strength of fidelity and perseverance.
Keywords: Malaria, genetics, female mosquitos, Sotrastaurin
NEWSLETTERS »
Rate This Article
1 - 1 of 1 Comments
Leave a Comment
More Health News
- Forget printing guns, doctors use 3D printer to save baby
- Is it really that simple? - Research suggests ordinary vitamin C kills drug-resistant TB
- Chamomile tea can be refreshing treat - as well as a safeguard against cancer, researchers say
- HIV resurgent among Navajo tribe as deadly cases spike
- UK to give cancer patients genetic analysis just like Angelina Jolie
- Vitamin D found beneficial in treating asthma symptoms
- Study: Depressed women in 40s, 50s suffer more than twice for stroke risk
- Some experts say it's biologically possible to clone a human
- Study: Women live longer than men as their immune systems age more slowly
Featured News
- Fr. Paul Schenck: Finding Living Faith on Catechetical Sunday
- The Movie Yellow: Incest as 'Normal' and Cassavates's Slides Into the World of Woes
- The Chicago School Teachers Strike Reveals the Need For School Choice
- The Sexual Barbarians and the Dissolution of Culture
- The Happy Priest Challenges Us to Ask: Who is Jesus to Me?
- Michael Coren on Canadian Public Schools: Teachers, leave those kids alone
- We Cannot Ignore Our Consciences: Cardinal Dolan On Religious Liberty
- In the Face of Danger, Successor of Peter Travels to Lebanon as a Messenger of Peace
- Reflections on the Dignity and Vocation of Women: Who or What?
Most Popular
Pope Francis says atheists can do good and go to heaven too! Read More
There's the problem! Americans are out of touch with scientific consensus on climate change Read More
Culture of Corruption: Why Obama's misuse of Marines is wrong Read More
Bill Donohue, Catholic League, Disclose Fight with the IRS, Demonstrate Courage Read More
Receiving the Eucharist: I Have Decided to Kneel For Jesus Read More
Marketplace
Of Moose and Miracles
This is a heart-rending story of faith, family and God’s omnipotent ... Read More
Graduation. Catholic Gift. Doctor, Dentist. St Raphael Necklace. Read More




Print















I have interest in your work on malaria targeting PKC.because i am involved in a similar work but using antihistamine, which through PfTCTP, IP3 and DG elaboration increases PKC production resulting in lack of immunity to Malaria.
My experience with this antihistamine use in combination with antimalarial over a period of 12 years now shows that it offers cure and long term immunity to malaria for a period of more than seven years.
In absence of a vaccine for malaria at the moment, this could be a solution to malaria.
I am willing to join your researchers to prove my hypothesis.
Best regards,
Dr. Akusa Yuma Darlington,
Arua Regional Referral Hospital,
P.O Box 3,
Arua,
Uganda